XML 14 R7.htm IDEA: XBRL DOCUMENT v3.26.3
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 49,680,921 $ 45,789,360 [1]
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change unrealized (appreciation) depreciation on derivative instruments (3,408,850) 875,296
Net change unrealized (appreciation) depreciation on foreign currency 3,499,154 (2,194,761)
Net realized (gain) loss on derivative instruments (1,233,505) 1,083,416
Net realized (gain) loss on foreign currency (1,162,649) (14,689)
Payment-in-kind interest capitalized (6,268,103) (4,321,405)
Net accretion of discount and amortization of premium (5,417,571) (9,411,671)
Amortization of deferred financing costs 609,900 570,931
Amortization of offering costs 279,840 569,023
Purchases of investments (462,790,341) (633,689,223)
Cash settlement of derivatives 1,343,492 (1,091,562)
Proceeds from sale of investments and principal repayments 254,823,633 377,329,070
Changes in operating assets and liabilities:    
Interest receivable (2,958,145) (189,809)
Receivable for investments sold (2,704,281) (2,394,769)
Due from Advisor 0 74,454
Other assets (223,481) (95,137)
Payable for investments purchased (10,420,667) 11,710,302
Due to Advisor and affiliates (8,695) 205,710
Management fee payable 300,840 530,997
Income incentive fee payable 56,169 1,713,460
Accrued capital gains incentive fee (581,508) (371,180)
Interest and credit facility fees payable 852,723 1,157,901
Accrued expenses and other liabilities 26,729 859,682
Net cash provided by (used in) operating activities (181,004,735) (207,636,262)
Cash flows from financing activities:    
Proceeds from Secured Credit Facility 246,566,000 230,619,000
Repayment of Secured Credit Facility (161,566,000) (128,804,745)
Proceeds from Repurchase Obligations 55,657,829 0
Deferred financing cost paid (504,756) (75,000)
Distributions paid in cash (33,126,516) (17,400,245)
Deferred offering costs paid (214,335) (340,793)
Proceeds from issuance of common shares 32,305,168 126,581,146
Redemptions paid in cash (12,380,946) (545,604)
Net cash provided by (used in) financing activities 126,736,444 210,033,759
Net increase (decrease) in cash, cash equivalents and restricted cash (54,268,291) 2,397,497
Cash, cash equivalents and restricted cash, beginning of period 92,657,563 37,743,294
Cash, cash equivalents and restricted cash, end of period 38,389,272 40,140,791
Supplemental information and non-cash activities:    
Cash paid for interest 20,719,681 19,988,518
Restructuring of portfolio investments 0 23,085,896
Reinvestment of distributions 50,685,175 40,762,486
Accrued but unpaid deferred financing cost 1,431,250 0
Accrued but unpaid deferred offering cost 337,986 16,428
Non-controlled/Non-affiliated Investments [Member]    
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change unrealized (appreciation) depreciation on investments 1,592,730 10,744,325
Net realized (gain) loss on investments 893,676 (6,144,647)
Non-controlled/affiliated [Member]    
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change unrealized (appreciation) depreciation on investments 206,036 0
Controlled/affiliated Investments [Member]    
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change unrealized (appreciation) depreciation on investments $ 2,007,218 $ (931,336)
[1] There were no Class D shares outstanding during the three and nine months ended September 30, 2025.